COnteMporary Modalities In Treatment of Heart Failure: a report from the COMMIT-HF registry

Area of Science:

• Cardiology
• Clinical Research
• Public Health

Background:

• Heart failure (HF) presents a significant global health challenge, contributing substantially to hospital admissions and carrying a poor prognosis.
• A high-volume cardiovascular center initiated the COMMIT-HF study to analyze clinical data, therapies, and outcomes in a large cohort of HF patients.
• Systolic HF, defined by left ventricular ejection fraction (LVEF) ≤ 35%, was the focus, excluding acute coronary syndromes.

Purpose of the Study:

• To analyze clinical data, administered therapies, and prognosis in a large cohort of patients with systolic heart failure.
• To provide valuable insights into the characteristics and outcomes of a complex HF patient population.
• To assess the feasibility of achieving satisfactory long-term results in HF management.

Main Methods:

• The COMMIT-HF study is a single-center observational study conducted at the Silesian Centre for Heart Diseases.
• The study enrolled 1798 adult HF patients with LVEF ≤ 35%, excluding those with acute coronary syndromes.
• Data collected included demographics, medical history, diagnostic and therapeutic hospitalisation data, and 12-month follow-up via national health-care provider records.

Main Results:

• The enrolled cohort (n=1798) had a mean age of 60.9 years, with 20.3% females and a mean LVEF of 26.06%.
• Common comorbidities included ischemic etiology (64.5%), atrial fibrillation (33.2%), diabetes mellitus (41.2%), and chronic kidney disease (29%).
• High rates of invasive procedures were observed, including ICD/CRT-D implantation (61.1%) and coronary angiography (56.2%). All-cause 12-month mortality was 12.5%, with a 28.9% HF-related rehospitalisation rate.

Conclusions:

• The COMMIT-HF study offers crucial data on a challenging heart failure patient population.
• Initial findings suggest that effective management strategies can lead to satisfactory long-term outcomes even in complex HF cases.
• The study underscores the importance of comprehensive diagnostics and therapy in improving HF patient prognosis.